Treating stage I nonseminomatous germ cell tumours with a single cycle of chemotherapy

BJU International

Volumn 98, Issue 1, 2006, Pages 67-69

  Gilbert, Duncan C ^a   Norman, Andrew R ^a   Nicholl, Judith ^a   Dearnaley, David P ^a   Horwich, Alan ^a   Huddart, Robert A ^a  

^a INSTITUTE OF CANCER RESEARCH   (United Kingdom)

Author keywords

Adjuvant chemotherapy; Testicular germ cell tumours

Indexed keywords

BLEOMYCIN; CARBOPLATIN; CISPLATIN; ETOPOSIDE; TUMOR MARKER;

ADULT; ARTICLE; CANCER CHEMOTHERAPY; CANCER RELAPSE; CANCER RISK; CANCER STAGING; CLINICAL ARTICLE; COHORT ANALYSIS; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; FOLLOW UP; HUMAN; MALE; NON SEMINOMATOUS GERMINOMA; ORCHIECTOMY; PRIORITY JOURNAL; TESTIS;

ADULT; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BLEOMYCIN; CARBOPLATIN; CHEMOTHERAPY, ADJUVANT; CISPLATIN; ETOPOSIDE; HUMANS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOPLASMS, GERM CELL AND EMBRYONAL; TESTICULAR NEOPLASMS; TREATMENT OUTCOME;

EID: 33745075685     PISSN: 14644096     EISSN: 1464410X     Source Type: Journal    
DOI: 10.1111/j.1464-410X.2006.06188.x     Document Type: Article

References (10)

1. Read G Stenning SP Cullen MH et al. Medical Research Council prospective study of surveillance for stage I testicular teratoma. Medical Research Council Testicular Tumours Working Party. J Clin Oncol 1992 10: 1762 8
2. Albers P Siener R Kliesch S et al. Risk factors for relapse in clinical stage I nonseminomatous testicular germ cell tumors: results of the German Testicular Cancer Study Group Trial. J Clin Oncol 2003 21: 1505 12
3. Vergouwe Y Steyerberg EW Eijkemans MJ Albers P Habbema JD. Predictors of occult metastasis in clinical stage I nonseminoma: a systematic review. J Clin Oncol 2003 21: 4092 9
4. Cullen MH Stenning SP Parkinson MC et al. Short-course adjuvant chemotherapy in high-risk stage I nonseminomatous germ cell tumors of the testis: a Medical Research Council report. J Clin Oncol 1996 14: 1106 13
5. Huddart RA Norman A Shahidi M et al. Cardiovascular disease as a long-term complication of treatment for testicular cancer. J Clin Oncol 2003 21: 1513 23
6. Meinardi MT Gietema JA van der Graaf WT et al. Cardiovascular morbidity in longterm survivors of metastatic testicular cancer. J Clin Oncol 2000 18: 1725 32
7. Travis LB Curtis RE Storm H et al. Risk of second malignant neoplasms among long-term survivors of testicular cancer. J Natl Cancer Inst 1997 89: 1429 39
8. Bokemeyer C Schmoll HJ. Secondary neoplasms following treatment of malignant germ cell tumors. J Clin Oncol 1993 11: 1703 9
9. Oliver RT Mason MD Mead GM et al. Radiotherapy versus single-dose carboplatin in adjuvant treatment of stage I seminoma: a randomised trial. Lancet 2005 366: 293 300
10. Schefer H Mattmann S Borner M et al. Single course adjuvant bleomycin, etoposide and cisplatin (BEP) for high risk stage I non-seminomatous germ cell tumors (NSGCT). ASCO Thirty-Sixth Annual Meeting; May 20-23, 2000. New Orleans, LA: Program/Proceedings of ASCO 2000: 340A